Lapsed Apr 29, 2026 on the fee record · High confidence
20-year base term ends Dec 8, 2030
Third maintenance fee unpaid; grace period ended.
Held by Nitto Denko Corporation
Filed Dec 8, 2010 as application 12/963,600 · Granted Apr 29, 2014
Base term, 20 years from filing, plus 71 days of patent term adjustment (USPTO delay)
Today
Lapsed Apr 29, 2026
2010
2031
Clock starts
Dec 8, 2010
Dec 8, 2010
No longer in force
Apr 29, 2026
Apr 29, 2026
Granted
Apr 29, 2014
Apr 29, 2014
Term would have run to
Feb 17, 2031
Feb 17, 2031
base term
patent term adjustment
after the term ends
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
71
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Feb 17, 2031: its 20-year base term plus 71 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 8, 2010, when this application, 12/963,600, was filed | Dec 8, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +71 days, USPTO patent term adjustment record | Feb 17, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Apr 29, 2026 | High confidence |
| Computed term end | The steps above, in order | Apr 29, 2026 | High confidence |
Partial family
| US 8,710,209 | this patent Apr 2026 | Apr 2026 |
| Application PCT/JP2012/079783 | PCT application no patent term | no patent term |
| US 9,206,424 | In force Dec 2030 | Dec 2030 |
| Application 14/359,079 | Abandoned not computed | not computed |
| US 10,093,923 | Lapsed on the fee record Oct 2026 | Oct 2026 |
| Application 15/062,736 | Abandoned not computed | not computed |
| Application 15/645,382 | Abandoned not computed | not computed |
Partial: 1 of the 7 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 3, 2011 Reel 25896, frame 865 | Feinstein, Elena; Avkin-nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C. | Quark Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Mar 7, 2011 Reel 25910, frame 37 | Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro | Nitto Denko Technical Corporation | Assignment of Assignor's Interest |
| Mar 31, 2011 Reel 26058, frame 657 | Jin, Xiaomei | Nitto Denko Technical Corporation | Assignment of Assignor's Interest |
| Aug 4, 2011 Reel 26699, frame 495 | Quark Pharmaceuticals, Inc.; Q.B.I. Enterprises Ltd. | Nitto Denko Corporation | Patent Security Agreement |
| Aug 4, 2011 Reel 26700, frame 1 | Quark Pharmaceuticals, Inc.; Q.B.I. Enterprises Ltd. | Nitto Denko Corporation | License |
| Feb 8, 2012 Reel 27674, frame 532 | Quark Pharmaceuticals, Inc.; Q.B.I. Enterprises Ltd. | Nitto Denko Corporation | License |
| Feb 8, 2012 Reel 27675, frame 517 | Quark Pharmaceuticals, Inc.; Q.B.I. Enterprises Ltd. | Nitto Denko Corporation | Patent Security Agreement |
| Apr 18, 2012 Reel 28063, frame 942 | Nitto Denko Technical Corporation | Nitto Denko Corporation | Assignment of Assignor's Interest |
| May 3, 2012 Reel 28152, frame 1 | Chen, Ning | Nitto Denko Corporation | Assignment of Assignor's Interest |
| Aug 12, 2013 Reel 30993, frame 365 | Quark Pharmaceuticals, Inc. | Nitto Denko Corporation | Assignment of Assignor's Interest |
| Oct 11, 2013 Reel 31397, frame 788 | Nitto Denko Corporation | Nitto Denko Corporation | Change of Address |
| Oct 17, 2013 Reel 31431, frame 817 | Nitto Denko Corporation | Quark Pharmaceuticals, Inc.; Q.B.I. Enterprises Ltd. | Termination of License Agreement |
| Oct 17, 2013 reel/frame not recorded | Nitto Denko Corporation | Quark Pharmaceuticals, Inc. | Termination of License Agreement |
| Oct 17, 2013 reel/frame not recorded | Nitto Denko Corporation | Q.B.I. Enterprises Ltd. | Termination of License Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 71 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
36
later US patents cite this one
That is top 25% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.